Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Saving quickly for a home is possible with the right strategies. Explore practical methods to boost your savings and reach your goal.
17,968 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Ford is recalling 4.4 million vehicles worldwide after a software flaw increases crash risk for trailers. The move un...
February brought a sharp move in Hycroft Mining stock as gold and silver prices rose and investors weighed future pro...
Public appearances in today’s media age can trigger real financial consequences. This article uses Erika Kirk as a co...
AI-driven cyber threats are accelerating, but the WisdomTree Cybersecurity Fund remains under pressure as its index c...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
Investors often wonder if the memory chip darling Micron is still worth buying after a big run. This guide breaks dow...
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...
In 2026, corporate bond spreads tightening is reshaping risk and return for the iShares LQD ETF, as yields, credit qu...
The native token of a leading worldcoin rival, Humanity Protocol’s H token, plunged 88% after a major wallet breach d...
AbbVie blew past first-quarter expectations with a $15.002 billion revenue print and raised full-year guidance, under...
Cerebras Systems stock crashed after its latest earnings report, leaving investors asking what happened and what come...